ALB and End Stage Liver Disease: The AUCs of the cisterna chyli diameter, age, albumin, sodium, blood urea nitrogen (BUN), BUN/creatinine, c-reactive protein, model for end-stage liver disease score, fractional excretion of sodium, and urinary sodium for evaluating the effect of tolvaptan were 0.911, 0.539, 0.597, 0.551, 0.656, 0.631, 0.547, 0.587, 0.627, and 0.5, respectively.